Isolated CNS relapse of medullary aggressive high-grade B-cell lymphoma on 18F-FDG-PET/CT

Isolated CNS relapse of medullary aggressive high-grade B-cell lymphoma on 18F-FDG-PET/CT

Abstract This is a case of high-risk, aggressive, high-grade medullary B-cell lymphoma presenting with new onset of neurological dysfunction following initial complete response to the standard chemoimmunotherapy. A whole-body re-staging PET using fluorodeoxyglucose (18F-FDG) integrated with computed...

Full description

Bibliographic Details
Main Authors:	Gerard Lambe, Simon Doran, Ruth Clifford, Afshin Nasoodi
Format:	Article
Language:	English
Published:	SpringerOpen 2022-05-01
Series:	European Journal of Hybrid Imaging
Subjects:	Positron emission tomography Secondary CNS lymphoma Spinal cord
Online Access:	https://doi.org/10.1186/s41824-022-00130-9

Similar Items

Multiply Relapsed Secondary CNS Non-Germinal Center Diffuse Large B-Cell Lymphoma Successfully Treated with CNS-Centric Therapy
by: Fournier LL, et al.
Published: (2023-08-01)

Circulating microRNAs in Cerebrospinal Fluid and Plasma: Sensitive Tool for Detection of Secondary CNS Involvement, Monitoring of Therapy and Prediction of CNS Relapse in Aggressive B-NHL Lymphomas
by: Pavle Krsmanovic, et al.
Published: (2022-05-01)

18FDG PET in lymphoma
by: Goldsmith Stanley J.
Published: (2012-01-01)

PRIMARY CNS LYMPHOMA MIMICKING TUBERCULOSIS INFECTION - A CASE REPORT
by: Hassan Mumtaz, et al.
Published: (2021-12-01)

Cranial Radiation Therapy as Salvage in the Treatment of Relapsed Primary CNS Lymphoma
by: Matthew E. Volpini, et al.
Published: (2022-10-01)

Update on Novel Therapeutics for Primary CNS Lymphoma
by: Lauren R. Schaff, et al.
Published: (2021-10-01)

Functional Outcome and Overall Survival in Patients with Primary or Secondary CNS Lymphoma after Surgical Resection vs. Biopsy
by: Franziska Staub-Bartelt, et al.
Published: (2023-11-01)

A unique case of a fulminant clonal CD8-positive T-cell lymphoproliferative disorder with CNS involvement
by: Lia Mesbah-Oskui, et al.
Published: (2023-09-01)

FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma—An Updated Overview
by: Conrad-Amadeus Voltin, et al.
Published: (2020-03-01)

Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy
by: Isabel Cornell, et al.
Published: (2023-07-01)

CNS Involvement of DLBCL Presenting with an Unusual Non-Enhancing Infiltrative Mass
by: Fu-Sheng Hsueh, et al.
Published: (2023-11-01)

Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy
by: Kebir Sied, et al.
Published: (2012-12-01)

Neurosurgical Management of Central Nervous System Lymphoma: Lessons Learnt from a Neuro-Oncology Multidisciplinary Team Approach
by: Maria Alexandra Velicu, et al.
Published: (2023-04-01)

Long‐term outcomes of frontline intensification in primary CNS lymphoma: A real‐world single‐center experience
by: Hao‐Yuan Wang, et al.
Published: (2023-04-01)

Predictive impact of soluble interleukin‐2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B‐cell lymphoma
by: Takafumi Shichijo, et al.
Published: (2022-05-01)

Is There an Indication for First Line Radiotherapy in Primary CNS Lymphoma?
by: Clemens Seidel, et al.
Published: (2021-05-01)

Primary dural Lymphoma: A case report
by: IBRAHIM Al-hassana Idriss, et al.
Published: (2024-06-01)

Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma
by: Hans-Georg Wirsching, et al.
Published: (2021-06-01)

Pretreatment diffusion-weighted imaging for prediction of relapsed and refractory primary central nervous system lymphoma
by: Hsi-Cheng Chien, et al.
Published: (2023-08-01)

Cultured Cells Isolated from CNS Indolent B- Cell Lymphoma Have Characteristics of Mesenchymal Stem Cells: A Clinical Case and Scientific Research
by: Kalina Tumangelova-Yuzeir, et al.
Published: (2018-07-01)

Intravascular Large B Cell Lymphoma with CNS Involvement Successfully Treated with High-Dose Methotrexate and High-Dose Ara-C Based CNS-Directed Chemoimmunotherapy Alternating with Anthracycline Based Chemoimmunotherapy
by: Wang J, et al.
Published: (2022-05-01)

FDG PET/CT versus Bone Marrow Biopsy for Diagnosis of Bone Marrow Involvement in Non-Hodgkin Lymphoma: A Systematic Review
by: Jawaher Almaimani, et al.
Published: (2022-01-01)

Sarcoidosis in Close Family Members and Susceptibility to High Grade B-Cell Lymphoma: A Case Report Study
by: Hana Magrouni, et al.
Published: (2022-11-01)

Advances in the application of 18F-FDG PET/CT radiomics for diagnosis, treatment and prognosis prediction of lymphoma
by: CHENG Ran, et al.
Published: (2023-06-01)

Real-world experiences of CNS-directed chemotherapy followed by autologous stem cell transplantation for secondary CNS involvement in relapsed or refractory diffuse large B-cell lymphoma
by: Sun Young Jeong, et al.
Published: (2023-01-01)

Fractionated Stereotactic Radiation for Central Nervous System Lymphoma: Retrospective Analysis of Initial Cases
by: Daniel G. Schep, et al.
Published: (2023-09-01)

Predictive value of Dmax and %ΔSUVmax of 18F-FDG PET/CT for the prognosis of patients with diffuse large B-cell lymphoma
by: Jun Dang, et al.
Published: (2023-10-01)

Metabolic bulk volume from FDG PET as an independent predictor of progression-free survival in follicular lymphoma
by: Heejune So, et al.
Published: (2023-11-01)

Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia
by: Judit C. Sági, et al.
Published: (2021-05-01)

FDG-PET in mantle cell lymphoma involving skin
by: Mehmet Sönmez, et al.
Published: (2010-12-01)

Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma
by: Vijay Mistry, et al.
Published: (2023-01-01)

Dural involvement in central nervous system langerhans cells histiocytosis (LCH) on FDG PET/CT: Case report and review of CNS manifestations of LCH on PET/CT
by: Assim Saad Eddin, et al.
Published: (2024-04-01)

Survival, prognostic factors, hospitalization time and clinical performance status after first cerebral relapse or progression in 54 patients with primary CNS lymphoma not eligible for high dose chemotherapy: a retrospective analysis
by: Sabine Seidel, et al.
Published: (2023-02-01)

Emerging Landscape of Immunotherapy for Primary Central Nervous System Lymphoma
by: Marion Alcantara, et al.
Published: (2021-10-01)

18F-FDG positron emission tomography in the diagnosis and staging of marginal zone non-Hodgkin lymphomas
by: M. M. Khodzhibekova, et al.
Published: (2016-02-01)

Acquired factor VII inhibitor associated with primary central nervous system Lymphoma: A case report
by: Vanshika Goyal, et al.
Published: (2022-08-01)

Primary Central Nervous System Lymphoma in Elderly Patients: Management and Perspectives
by: Andrea Morales-Martinez, et al.
Published: (2021-07-01)

Pre-treatment [18F]FDG PET/CT for assessing bone marrow involvement and prognosis in patients with newly diagnosed peripheral T-cell lymphoma
by: Jing Chen, et al.
Published: (2024-12-01)

The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma
by: Huanyu Gong, et al.
Published: (2023-02-01)

Relapsed isolated CNS lymphoma treated with radiotherapy and intrathecal methotrexate followed by high‐dose intravenous methotrexate, rituximab, and temozolomide: A case report
by: Ikhwan Rinaldi, et al.
Published: (2024-03-01)